U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07176689) titled 'Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)' on July 31.
Brief Summary: This study is being conducted to study how nirogacestat may affect the ovarian function of adult premenopausal women with progressing desmoid tumors/aggressive fibromatosis.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Desmoid Tumor
Aggressive Fibromatosis
Intervention:
DRUG: Nirogacestat
Nirogacestat oral tablet
Recruitment Status: RECRUITING
Sponsor: SpringWorks Therapeutics, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....